Skip to content

Clinical trials

Schizophrenia, Treatment-Resistant trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia, Treatment-Resistant Country / region: Canada Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20111
20121
20151
20171
20191
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health3
Ciusss de L'Est de l'Île de Montréal3
Daniel Benjamin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia7
Schizophrenia, Treatment-Resistant7
Hallucinations4
Psychotic Disorders2
Adenoviridae Infections1
Anxiety Disorders1
Arrhythmias, Cardiac1
Autistic Disorder1
Bipolar Disorder1
Bradycardia1

Trials

Showing 26 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.